Fluorescence imaging agent EMI-137
Term · Oncology and biomedicine · MLC-T-ONC-013649
A water-soluble compound composed of a 26-amino acid cyclic peptide targeting the human hepatocyte growth factor receptor (c-MET) conjugated to a cyanine-based fluorescent dye, with potential fluorescent imaging activity. Upon administration of EMI-137, the peptide moiety specifically targets and binds to the human tyrosine kinase receptor c-Met, which is often overexpressed on cancer cells. Upon imaging, the cancer cells can be visualized.
| Identifier | MLC-T-ONC-013649 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013649",
"term": "Fluorescence imaging agent EMI-137",
"field": "Oncology and biomedicine",
"definition": "A water-soluble compound composed of a 26-amino acid cyclic peptide targeting the human hepatocyte growth factor receptor (c-MET) conjugated to a cyanine-based fluorescent dye, with potential fluorescent imaging activity. Upon administration of EMI-137, the peptide moiety specifically targets and binds to the human tyrosine kinase receptor c-Met, which is often overexpressed on cancer cells. Upon imaging, the cancer cells can be visualized.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/fluorescence-imaging-agent-emi-137/"
}
Record 7,394 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.